Cloudpharm’s team members visited the University of Bari Aldo Moro in January to attend the partner meeting and training workshop in the framework of the European Project #Neghtra. Next Generation Training on Intelligent Greenhouses (NEGHTRA) aims to provide...
NEWS
Participation in Neo4j Online Developer Education Summit NODES 22
Our “one-stop-shop” next-generation drug repurposing platform (CloudScreen) was presented in NODES 22, Neo4j Online Developer Education Summit. During the online advanced session, technology transfer took place by co-speakers and project members; S. Ouzounis, V....
Participation in the 15th Annual Skeletal Health Conference
On October 15th 2022, the «Butterfly» Bone Health Society organized the 15th annual Skeletal Health Conference at Divani Caravel Hotel. OSTEOME‘s representers were the coordinator of the project Associate Professor Panagiotis Zoumpoulakis, the Scientific Officer...
Cloudpharm is one of the 5 Greek startups entering the final phase of Pfizer’s Start4Health Challenge.
Our drug repurposing computational platform Cloudscreen, adopts next gen algorithms for drug repurposing and provides AI powered predictions towards novel indications for existing drugs, coupled with state-of-the-art validation tools. Cloudscreen is currently being...
Cloudpharm announces strategic partnership with Cosmos Holdings
We are very excited to announce the partnership with Cosmos Holdings (NASDAQ:COSM), to develop new products targeting the gut microbiome. Our mission is closely aligned with Cosmos, as they are devoted to developing new and innovative products using high-quality...
Cloudpharm gets funding for drug repurposing platform, Cloudscreen
Cloudpharm announces the approval of the funded project “Cloudscreen” in collaboration with the Institute of Chemical Biology of the National Hellenic Research Foundation (NHRF). The objective of the project is the development of a next generation “one-stop-shop”...